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Positive health, dignity, and prevention (PHDP) interventions target people living with HIV
and AIDS (PLHIV) to promote well-being and prevent onward transmission. Concern that
increased life expectancy and improved well-being would lead to increased risky sexual
behaviour and subsequent HIV transmission motivated researchers to test novel strategies
to support treatment adherence, encourage safer sex, STI treatment and partner testing,
prevention of mother to child transmission, and support uptake of family planning.
Methods
We assessed the number and type of PHDPmessages delivered to PLHIV before and after
the implementation of an educational intervention for health providers combined with the
distribution of visual job aids and monthly technical assistance.
Results
From April 21, 2013 to March 20, 2014, we documented 54,731 clinical encounters at three
rural health centres in Zambézia province, Mozambique from 9,248 unique patients. The
percentage of patients who received all seven PHDPmessages during their last three visits
was 1.9% pre-intervention vs. 13.6% post- intervention (p=<0.001). Younger patients (25
years vs. 35) and those with a recent HIV diagnosis (two weeks vs. two years) had higher
odds of receiving any PHDPmessage (Odds Ratio [OR]: 1.22 and 2.79, respectively).
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Patients >59 days late collecting medications were not more likely to receive adherence
messages than adherent patients (p=0.17).
Discussion
Targeting HIV prevention efforts to PLHIV is an effective HIV prevention approach to elimi-
nate HIV transmission. Despite intensive training and support, PHDPmessage delivery
remained unacceptably low in rural Mozambique. Patients at high risk for treatment aban-
donment were not more likely to be counselled about adherence and support measures,
something that needs to be addressed.
Conclusions
We need to develop novel strategies to motivate health care providers to deliver these mes-
sages more consistently to all patients and develop a system that assists counsellors and
clinicians to quickly and effectively determine which messages should be delivered.
Introduction
Mozambique has one of the world’s highest burdens of human immunodeficiency virus (HIV)
and acquired immunodeficiency syndrome (AIDS), with an estimated 11.1% of the adult popu-
lation living with HIV [1]. The Mozambican Ministry of Health (MISAU) has partnered with
the Centers for Disease Control and Prevention (CDC) to provide nationwide free access to
HIV care and treatment. Given the generalized HIV epidemic, the current national strategy is
the antiretroviral therapy (ART) acceleration plan, which aims to have 85% of individuals who
are HIV infected, started on antiretroviral medication as directed through the World Health
Organization (WHO) HIV treatment guidelines [2]. Initiation, retention, and adherence to
ART reduces the risk of HIV transmission to sexual partners and infants [3, 4] and mortality
[5]. As a result, life expectancy for those initiating treatment with baseline CD4 counts>350
cells/mm3 is approaching that of the general population [6]. Concern that increased life expec-
tancy and improved well-being would lead to increased risky sexual behaviour and subsequent
HIV transmission [7–11] motivated researchers to test novel clinical strategies to support treat-
ment adherence, encourage safer sex, STI treatment and partner testing, and support uptake of
family planning services [12, 13].
Positive health, dignity, and prevention (PHDP), or as they are known in Mozambique, Pos-
itive prevention (PP) interventions, specifically target people living with HIV and AIDS
(PLHIV) to promote well-being and prevent onward transmission, including sexual transmis-
sion and mother-to-child transmission [14–20]. Strategies to improve PHDP behaviours have
included: clinical based couples counselling and testing,[21–25] counselling and increased
availability of family planning,[26] individualized clinician-delivered prevention interventions,
[27, 28] and group counselling and education for HIV-infected adults;[29] internet or com-
puter-based education sessions; [30] and peer-delivered HIV prevention interventions [31].
Most studies have shown that communication of prevention messages is effective at increasing
condom use and uptake of family planning services when done by a health care worker (HCW)
in a clinic setting [32–35]. Mozambique is one of the few countries that has prioritized PHDP
as part of their national strategy to address HIV prevention in all health facilities. The approach
in Mozambique is to train and enlist all health facility staff to ensure patients receive messages
Positive Prevention Message Delivery to PLHIV in Mozambique
PLOS ONE | DOI:10.1371/journal.pone.0130676 July 6, 2015 2 / 15
Funding: This research has been supported by the
President's Emergency Plan for AIDS Relief
(PEPFAR) through the U.S. Department of Health
and Human Services and the Centers for Disease
Control and Prevention (CDC) under the terms of
Cooperative Agreement Numbers 1U2GPS002770-
01, 5U2GPS002770-02, 5U2GPS002770-03 and
5U2GPS002770-04. The findings and conclusions
presented in this manuscript are those of the authors
and do not necessarily represent the official position
of the CDC. CMA was supported, in part, by a
Vanderbilt career development award, UL1TR000445
(PI Bernard) and NIMH No. 1K01MH107255-01.
Competing Interests: The authors have declared
that no competing interests exist
throughout the continuum of care. However, two primary challenges limit scale up of PHDP:
(1) low-resourced health infrastructure and staffing to meet the population demands; and (2)
extremely low health literacy levels among patients, estimated at 52% nationwide [36].
Training HCWs to incorporate PHDP message delivery and counselling into their clinical
services presents a solid, evidence-based approach to the prevention of HIV transmission by
those already infected [35]. Integrating PHDP into clinical service delivery in rural Mozam-
bique has remained a challenge, however, despite the introduction of an evidence-based curric-
ulum by the University of California, San Francisco (UCSF)[37, 38]. While PHDP training
materials and sessions were acceptable to both patients and providers,[37] delivery of PHDP
messages remained poorly documented in the medical record. The purpose of this study was to
assess the number and type of PHDP messages delivered to PLHIV before and after the imple-
mentation of an educational intervention for clinicians providing HIV care and treatment
combined with the distribution of job aids (including posters and flipcharts with images depict-
ing PHDP messages) to each clinical and counselling room.
Materials and Methods
Study Setting
Morrumbala, Pebane and Maganja da Costa are rural districts with estimated populations of
215,000 (Morrumbala and Pebane) and 305,000 (Maganja da Costa) respectively. Educational
attainment in the region is typically less than primary school and few people have any monthly
income [39]. The three district hospitals included in the study provide HIV testing, care and
treatment services (including ART), prevention of mother-to-child transmission (PMTCT),
family planning, and early infant diagnosis and treatment, free of charge. These sites were cho-
sen for their linguistic variability (they represent three distinct linguistic groups) and because
they provide all referral services described on the PHDP package of services
Study Population
All HIV-positive male and female patients aged 18 years with at least one contact (clinical
appointment, counselling session, or pharmacy pick-up) at one of the three study sites from
April 2013 to March 2014 were included in the study. Patients< 18 years of age enrolled in
care were excluded.
Positive Prevention Intervention Protocol
Every patient receiving HIV care and treatment in Mozambique should be provided PHDP
messages during clinical, counselling, and pharmacy visits [40]. These messages (part of the
Positive Prevention Toolkit) were developed by researchers at University of California, San
Francisco [41], from pilot studies in Maputo, Mozambique [37, 38, 42] and implemented as a
national strategy by the Ministry of Health in April 2013. Concurrently, a new form, the Ficha
de Avaliação Psicossocial e de Prevenção Positiva (Psychosocial Assessment and Positive Pre-
vention Record) was introduced into patient records to allow providers to document delivery
of PHDP messages during each clinical encounter (Fig 1). In November 2013, a four day short-
course PHDP training session for all HIV care and treatment clinicians and counsellors was
provided at the three study sites. The training focused on the importance of PHDP, how and
when to deliver messages, how to address patient barriers to service uptake, and how to use
new visual aids (a poster and flip-chart containing images of PHDP services and behaviours).
These providers were also given a PHDP poster and flip-chart for their offices which provide
visual images of PHDP messages to facilitate discussion with patients. Monthly technical
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assistance follow-up visits at the HCW’s clinical care site within four weeks of the training were
provided to improve the implementation of the PHDP intervention in their day-to-day work
and as a way to provide reinforcement for the skills taught in the enhanced PHDP training
package. Providers were trained to ensure that each patient received all seven messages (includ-
ing the most relevant PHDP 5 message) every three months (Table 1).
Data Management and Outcomes
Data was documented during each patient visit by the provider using the Ficha de Avaliação
Psicossocial e de Prevenção Positiva (a Ministry of Health approved form) and subsequently
entered into an OpenMRS Electronic Medical Records (EMR). Major categories of data
included: demographics (age, sex, marital status, service entry into program), routine clinical
information (pregnancy status, partner serostatus, use of ART, and last two pharmacy pick-
ups), and receipt of the seven PHDP messages at each clinical visit. Of primary interest was the
Fig 1. Psychosocial Evaluation and Positive Prevention form.
doi:10.1371/journal.pone.0130676.g001
Table 1. Positive Health, Dignity, and Prevention (PHDP) messages.
PHDP1 Sexual behavior and use of condoms
PHDP2 Reveal serostatus to partner/invite partner to test
PHDP3 Adherence to care and medication
PHDP4 Screening for sexually transmitted infections
PHDP5a Family planning service availability
PHDP5b PMTCT
PHDP6 Use of drugs and alcohol
PHDP7 Community support group referral
doi:10.1371/journal.pone.0130676.t001
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number of messages received. Additionally, type of message receipt was considered. The num-
ber and type of messages received occurs at the visit level and the database includes anywhere
from 1 to 21 visits per patient. Messages are detailed in Table 1.
Ethics considerations
This study was approved by the Vanderbilt University Institutional Review Board, the Univer-
sity of California, San Francisco Committee on Human Research, the Comité Nacional de Bioé-
tica a Saúde in Mozambique, and the Centers for Disease Control and Prevention in Maputo,
Mozambique and Atlanta, USA. The data utilized constitute fully de-identified data; the
research file has an encrypted identifier and does not include patient names, addresses, or ID
numbers. As the data was de-identified when it was collected, patient consent was not required.
Statistical methods
Patient characteristics were compared among those with visits before and after intervention
using descriptive statistics. The proportion of patients who received all seven PHDP messages
during their last three visits (excluding pharmacy-only visits) was compared using chi-square
test. This analysis was repeated for patients who received four of seven messages during the
same time period. The frequency and proportion of visits with PHDP message receipt were
compared before and after intervention using cluster-adjusted Wald statistics to account for
correlation between visits from the same patient.
Multivariable negative binomial regression with robust variance estimation was used to
determine whether the incidence of message receipt was higher post-training. Multivariable
logistic regression with robust variance estimation modelled receipt of any PHDP message as a
binary response variable. Both models included an indicator for pre-/post-training and adjusted
for health facility, time since HIV diagnosis, patient sex, and age. We hypothesized that message
receipt across patient sex would be different following training and that sites would have differ-
ential PHDPmessage delivery following training; thus, a three-way interaction effect was
included in both models for pre-/post-training, health facility, and patient sex. The robust
covariance estimates account for correlation of the count data across multiple patient visits. To
relax linearity assumptions in the logistic regression, we modelled age and time since HIV diag-
nosis using restricted cubic splines with 4 knots [43]. The database had a record for date of last
scheduled ART pickup and last actual ART pickup. We subsetted to each patient's last visit
occurring after the last pharmacy pick-up and consider only PHDP3 as the outcome of interest,
such that we modelled the probability of adherence message receipt using logistic regression.
The model included an indicator for late pharmacy pick-up (>59 days late) and adjusts for
pre-/post-intervention receipt, health facility, time since HIV diagnosis, patient sex, and age.
Additionally, we tested for an interaction between pre-/post-training and site to determine if
administration of the adherence message differed across site. To relax linearity assumptions, we
modelled age and time since HIV diagnosis using restricted cubic splines with 4 knots [43].
Marital status was missing for nearly 40% of patients and was excluded from regression models.
All regression models used complete cases with no imputation; missing data was minimal. All
statistical analyses were conducted using R-software 3.0.2 (www.r-project.org/).
Results
From April 21, 2013 to March 20, 2014, we documented 54,731 clinical encounters at Maganja
da Costa, Pebane, and Morrumbala from 9,248 unique patients. The number of visits per
patient during follow-up ranged from 1 to 21. Table 2 summarizes characteristics of eligible
participants. Participants were primarily female (70%), had a median age of 32 years
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(interquartile range [IQR]: 26–39), were taking ART (77%), and were living with a partner
(38%). Patients received up to three types of services at each visit: (1) medical consultation; (2)
medication pick-up; and (3) psychosocial counselling. Fig 2 shows a diagram: types of visits
during the study.
PEPFAR, the CDC and the Mozambican Ministry of Health recommend that each patient
receive all seven PHDP messages within three visits to the health facility. The percentage of
patients who received all seven PHDP messages during their last three visits pre-intervention
was 1.9% vs. 13.6% post- intervention (excluding pharmacy-only visits) (p-value<0.001).
We also computed the percentage of patients who received four of seven messages over the
same time period (with the assumption that clinicians may already know some messages
were not relevant to a particular person based on clinical or social history of the patient). We
found that only 14.8% received four messages pre-intervention vs. 38.5% post-intervention
(p-value <0.001).
Frequency of PHDP message delivery increased from pre- to post-intervention (Table 3:
Positive Prevention Message Receipt). Post-intervention, the most commonly delivered mes-
sages were: (1) the importance of adherence to ART (14%); (2) the importance of using con-
doms during sex (14%); and (3) the importance of revealing serostatus to partner/inviting
one’s partner to test (13%). Messages about use of drugs and alcohol, community support
groups, and family planning/PMTCT showed the greatest improvements, given extremely low
delivery levels pre-intervention.
Table 2. Summary of Patient Characteristics.
Maganja da Costa Pebane Morrumbala Combined
(n = 3405) (n = 3157) (n = 2686) (n = 9248)
Female, n(%) 2501 (73%) 2132 (68%) 1814 (68%) 6447 (70%)
Current ageb, median (IQR) 31 (26–38) 32 (26–41) 32 (26–39) 32 (26–39)
Age at enrollment, median (IQR) 29 (23–35) 30 (24–39) 29 (24–36) 29 (23–37)
Marital status, n(%)
Missing 1023 (30%) 1465 (46%) 1110 (41%) 3598 (39%)
Divorced 3 (< 1%) 1 (< 1%) 0 (0%) 4 (< 1%)
Living with partner 1405 (59%) 476 (28%) 291 (18%) 2172 (38%)
Married 341 (14%) 590 (35%) 735 (47%) 1666 (29%)
Never married 449 (19%) 535 (32%) 423 (27%) 1407 (25%)
Separated 1 (< 1%) 2 (< 1%) 2 (< 1%) 5 (< 1%)
Widowed 183 (8%) 88 (5%) 125 (8%) 396 (7%)
Currently pregnantb, n(%) 397 (12%) 205 (6%) 244 (9%) 846 (9%)
Currently on ARTb, n(%) 2552 (75%) 2389 (76%) 2178 (81%) 7119 (77%)
Time since HIV diagnosis (days), median (IQR) 399 (0–1220) 355 (0–1010) 528 (14–1430) 418 (0–1210)
Missing, n(%) 99 (3%) 175 (6%) 120 (4%) 394 (4%)
GAAC (community adherence groups) 310 (9%) 22 (1%) 456 (17%) 788 (9%)
Current visit typeb,c, n(%)
Consultation 2796 (82%) 1653 (52%) 1881 (70%) 6330 (68%)
Med pick-up 1736 (51%) 1659 (53%) 1497 (56%) 4892 (53%)
Counseling 542 (16%) 1385 (44%) 1505 (56%) 3432 (37%)
Interquartile range (IQR) comprises the 25th and 75th percentiles.
b Current variables reﬂect data from the ﬁrst visit during study period.
c Percentages may sum over 100%.
doi:10.1371/journal.pone.0130676.t002
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Table 4 shows factors associated with the number of messages received. Younger patients
and those more recently diagnosed with HIV were more likely to receive messages. Patient vis-
its including a clinical consultation or counselling contact had rates of message delivery almost
twice those of other patient visits. Message delivery was much higher after intervention than
before, the change differed by sex and site (p<0.001). The rate of message receipt for a female
patient in Morrumbala was almost four times greater post-intervention than pre-intervention
training. In contrast, the rate of message receipt for a female in Pebane post-intervention was
only 1.22 times greater than the rate at pre-intervention.
Results were similar when we looked at factors associated with any receipt of messages.
Younger patients (25 years vs. 35) and those with a recent HIV diagnosis (two weeks vs. two
years) had higher odds of receiving any PHDP message (Odds Ratio [OR]: 1.22 and 2.79,
respectively) (Table 5: Adjusted Odds Ratios for ANY PHDPMessage Receipt). Those who
received counselling had 5.1 times greater odds of receiving a message (vs. those who did not
receive counselling that visit), while those who received a clinical consultation had 2.54 times
the odds of receiving a message (vs. someone who did not receive a clinical consultation).
Fig 2. Types of Visits during Study Period.
doi:10.1371/journal.pone.0130676.g002
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People who collected medications from the pharmacy had 25% lower odds of receiving a mes-
sage (vs. those who did not pick up medication). This trend existed for all messages. Delivery
of any PHDP message increased for men and women at all three clinics post-intervention.
While improvements were noted in each clinic for every type of PHDP message, Pebane con-
sistently had lower odds of increased message delivery than Morrumbala and Maganja da
Costa.
We modelled the probability of adherence message delivery to determine if a patient being
more than 59 days late for pharmacy visit had higher odds of receiving an adherence message
receipt from clinicians. While there were statistically significant increases in adherence message
delivery pre- and post-intervention at all sites (data not shown), there was little evidence that
those who were non-adherent to their medication pick-up had higher odds of receiving a mes-
sage about the importance of adherence (OR: 1.23; 95% CI: 0.91–1.65; p = 0.18). Considering
adherence message receipt among all adult visits, messages about adherence were most com-
monly delivered by counsellors (OR: 3.82; 95%CI: 3.51–4.16) and clinicians (OR: 2.33; 95% CI:
2.12–2.57), with pharmacists least likely (OR: 0.73; 95% CI:0.67–0.78) to deliver messages.
Table 3. Receipt of Positive Prevention Messages during 54731 Patient Visits by Intervention Period.
Pre Post Combined P-valuea
(n = 34041) (n = 20690) (n = 54731)
Sexual behavior and use of condoms 2475 (7%) 2899 (14%) 5374 (10%) < 0.001
Reveal serostatus to partner/invite partner to test 2043 (6%) 2767 (13%) 4810 (9%) < 0.001
Adherence to care and medication 2482 (7%) 2887 (14%) 5369 (10%) < 0.001
Sexually transmitted infections 1296 (4%) 2387 (12%) 3683 (7%) < 0.001
Family planning 1051 (3%) 1924 (9%) 2975 (5%) < 0.001
PMTCT 736 (2%) 1718 (8%) 2454 (4%) < 0.001
Use of drugs and alcohol 773 (2%) 2235 (11%) 3008 (5%) < 0.001
Community support group referral 503 (1%) 1695 (8%) 2198 (4%) < 0.001
a Tests of association based on cluster-adjusted Wald statistics that account for correlation between visits from the same patient. There are 9248 patients
and 54731 visits included in this table. During pre-intervention, 7702 patients were seen, and during post intervention 6734 patients were seen; among
these, 5188 had visits both pre- and post-intervention. The most visits for any one patient pre-intervention was 15 and post-intervention was 13 visits.
doi:10.1371/journal.pone.0130676.t003
Table 4. Adjusted incident rate ratios for number of messages received in a visit.
Incident Rate Ratio (95% CI)
Age (per 1 year increase) 0.98 (0.98, 0.99)
Time since HIV diagnosis (per 1 sqrt-day increase) 0.98 (0.97, 0.98)
Consultation 2.01 (1.86, 2.17)
Pharmacy pick-up 0.73 (0.69, 0.77)
Counseling 2.91 (2.72, 3.11)
Contrasts of Post vs. Pre (ref)
Female at Maganja da Costa 1.84 (1.68, 2.02)
Male at Maganja da Costa 2.59 (2.05, 3.28)
Female at Morrumbala 3.73 (3.16, 4.42)
Male at Morrumbala 3.66 (2.44, 5.47)
Female at Pebane 1.22 (1.01, 1.46)
Male at Pebane 2.48 (1.59, 3.86)
doi:10.1371/journal.pone.0130676.t004
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Discussion
While HIV risk reduction interventions for PLHIV have been shown to be effective in the
United States [44–47], few programs have focused on developing HIV prevention interventions
within clinical settings for PLHIV in African contexts, despite the need for these. One success-
ful program in South Africa has found that PHDP interventions can be delivered with fidelity
with counsellors providing the majority of intervention steps during visits [33, 34]. The results
of another prevention intervention package for healthcare and treatment settings in Kenya,
Namibia, and Tanzania are yet to be released [48, 49]. In Mozambique, in addition to a
National ART acceleration plan that seeks to reach 85% of infected Mozambicans with antire-
troviral medication, the Ministry of Health is using Positive Prevention/ PHDP, a health educa-
tion and behavioural approach, towards facilitating better HIV outcomes and less HIV
transmissions [40]. In this study in rural Mozambique, we assessed whether a PHDP training
approach focused on using updated training materials, support guides and job aides along with
monthly HCW technical assistance follow-up visits would improve the delivery of PHDP mes-
sages during clinical encounters, as documented in the clinical record. Overall, as a result of the
PHDP training and follow-up approach, improvements were seen in both the percentage of
patients who received all seven PHDP messages during their last three visits as well as the per-
centage of patients who received each individual PHDP message, but the proportion of patients
receiving adequate PHDP messages remains sub-optimal. Despite intensive training and sup-
port, PHDP message delivery remained unacceptably low in rural Mozambique. We need to
Table 5. Adjusted Odds Ratios for ANY PPMessage Receipt.
Odds Ratio (95% CI)
Age
25 years 1.22 (1.15, 1.30)
35 years (ref) 1
45 years 0.91 (0.86, 0.97)
Time since HIV diagnosis
Recent (two weeks) 2.79 (2.51, 3.11)
One year 1.31 (1.27, 1.35)
Two years (ref) 1
Five years 1.48 (1.35, 1.63)
Consultation 2.54 (2.34, 2.77)
Pharmacy pick-up 0.75 (0.70, 0.80)
Counseling 5.10 (4.71, 5.52)
Contrasts of Post vs. Pre (ref)
Female at Maganja da Costa 2.01 (1.82, 2.23)
Male at Maganja da Costa 2.61 (2.17, 3.14)
Female at Morrumbala 3.38 (3.02, 3.78)
Male at Morrumbala 3.28 (2.73, 3.94)
Female at Pebane 1.50 (1.29, 1.75)
Male at Pebane 2.49 (1.86, 3.32)
Age and time since diagnosis are modeled using restricted cubic splines with 4 knots.
Tests of association: age (p < 0.001), time since HIV diagnosis(p < 0.001), sex, (p < 0.001), clinic
(p < 0.001), intervention (p < 0.001), clinic consultation (p < 0.001), pharmacy pick-up (p < 0.001),
counseling visit (p < 0.001), three-way interaction of sex-clinic-intervention (p = 0.017).
doi:10.1371/journal.pone.0130676.t005
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develop novel strategies to motivate health care providers to deliver these messages more con-
sistently to all patients.
In this study younger patients and those with a recent HIV diagnosis had higher odds of
receiving PHDP messages. While we did not investigate provider rational for message deliv-
ery focused on these two populations the literature suggests: (1) younger HIV-positive
patients engage in higher risk behaviour than older adults; (2) clinicians are more comfort-
able addressing prevention with younger patients and those new to HIV care; and (3) patients
newly-engaging in care have the least information and thus are in need of a greater amount
of counselling [50–54]. Several studies correlate younger age with HIV risk behaviour in
HIV-positive clinic samples [50–52]. Flickinger found that younger patients and those who
had a shorter duration of the patient provider relationship were more likely to report greater
sexual risk behaviour when compared with older, more established patients [54]. Duration of
the clinical relationship may indicate a more recent diagnosis [53] and HIV-positive patients
recently engaged in care report higher risk behaviours [11]. Other studies have indicated
that it is important to capitalize on those newly infected patients [55] because diagnosis
presents an opportunity to address prevention of transmission earlier in their illness. Offer-
ing continued messages to patients who have been living with HIV and engaged with services
however is also necessary as these patients will continue to have distinct and changing needs
over time [7, 56]. In addition, PHDP is not only about decreasing transmission but a method
of increasing the quality of care for HIV-positive individuals over time. Thus, it will be
necessary to work with providers on continuing to give attention to the needs of ongoing
patients.
HIV prevention needs to be multi-faceted and patients may feel that receiving information
and support from various sources is beneficial. In this study, counsellors were most likely to
offer patients a PHDP message, followed by clinical providers and lastly by pharmacy staff.
Counsellors had almost two times higher odds of giving patients a PHDP message compared to
clinical providers. These findings are not surprising given that in many health centres, there is
a shortage of trained clinicians both in Mozambique as well as in other African contexts [57–
59]. In such situations, counsellors tend to spend more time with patients addressing beha-
vioural issues than clinicians. Additionally, in the Mozambican context, counsellors play an
important role providing psycho-social support services. In various settings, counsellors have
been found to be effective at delivering HIV prevention messages [60, 61]. However, research
in the US has suggested that messages given by clinicians have the most impact on changing
the behaviours of HIV clients [32]. The lower number of messages given by clinicians, although
perhaps not surprising, is disappointing, given that messages from clinical providers have been
shown to be effective at reducing high risk behaviours [62] and may carry more weight. Clini-
cians should continue to be encouraged to help their patients reduce risk behaviours and may
be best placed to offer bio-medical messages about treatment for STIs and PMTCT, for exam-
ple. However, due to the patient volume and complex needs of PLHIV, various cadres could
offer HIV prevention messages so that comprehensive prevention that better meets the needs
of patients is offered.
For pharmacies and pharmacy staff who are serving and supporting patients with HIV, opti-
mal adherence is critical for improved health as well as prevention [63]. Our findings indicate
that patients were unlikely to receive information about the importance of, or support for,
adherence to ART during their pharmacy visits. Adherence, which is one of the PHDP mes-
sages, is a cornerstone of HIV prevention and care, and a visit to the pharmacy represents an
opportunity for both adherence assessment and counselling. However, pharmacy and medica-
tion dispensing has not historically been utilized to its fullest benefit especially in low and mid-
dle income countries [64]. However, recent study findings indicate that for patients using
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pharmacies with HIV specific services or having HIV pharmacy staff involved in HIV care is
associated both with improvements in ART adherence as well as facilitating an increase in the
proportion of patients with suppressed viral load [65] and higher medication refill rates [63].
Also, in a recent review [65], in all but one study, the contribution of an HIV pharmacist to
patient care was associated with clinically and statistically significant improvements in ART
adherence. Supporting patients with HIV to achieve ART adherence is important for patients
and because of the low documented number of PHDP messages given during pharmacy visits,
this is an area that could be targeted for improvement in the delivery of PHDP. This represents
a missed opportunity for pharmacy staff to offer an appropriate PHDP message, prevention
education and behavioural support.
There are several limitations to our study. The pre-post design is vulnerable to a time bias
(perhaps PHDP message delivery was improving due to an undocumented outside effect,
unrelated to our training and materials). In this study, documentation of PHDP messages on
the Ficha de Avaliação Psicossocial e de Prevenção Positiva was used as proxy for PHDP mes-
sages delivered. Clinicians may be delivering messages but may not document this delivery,
despite training and recommendations (resulting in under-reporting). Alternatively, clini-
cians may be documenting message delivery which never occurred or which patients do not
understand (resulting in over-reporting). If a clinician knows the patient, and believes a mes-
sage will be of no value (for example, they know the person does not drink alcohol or is not
sexually active) it is reasonably certain messages will not be provided. This will result in
apparent under-delivery of messages, but would not result in a negative impact on the
patient’s well-being.
Conclusions
For the thousands of individuals living with or at risk for HIV in Mozambique, HIV prevention
is paramount. Targeting HIV prevention efforts with individuals who are aware of their infec-
tion is one of the most effective HIV prevention approaches we have towards eliminating HIV
transmission. An effective approach to preventing the transmission of HIV includes supporting
prevention efforts at the point of clinical care. Our intervention improved PHDP message
delivery in rural Mozambique, but despite intensive training using established materials and
monthly follow-up with all providers, PHDP message delivery remained unacceptably low. We
need to develop novel strategies to motivate health care providers to deliver these messages
more consistently to all patients.
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